Table 1.
Characteristics, practices, guidelines | N | None | A Few (<20%) | Several | Most (>90%) |
% * | % * | % * | % * | ||
Race/Ethnicity of patients treated over last 2 years | |||||
Non-Hispanic White | 75 | 1.3 | 9.3 | 60.0 | 29.3 |
Hispanic | 76 | 6.6 | 31.6 | 60.5 | 1.3 |
African American/Black | 77 | 9.1 | 52.0 | 39.0 | 0.0 |
Asian/Pacific Islander | 78 | 1.3 | 21.8 | 65.4 | 11.5 |
Patient decision-making preferences for treatment | |||||
Patient alone | 76 | 18.4 | 51.3 | 17.1 | 13.2 |
Patient with physician input | 78 | 0.0 | 10.3 | 39.7 | 50.0 |
Shared decision | 78 | 0.0 | 15.4 | 38.5 | 46.2 |
Physician with patient input | 76 | 13.2 | 60.5 | 21.0 | 5.3 |
Physician alone | 77 | 45.4 | 42.9 | 11.7 | 0.0 |
Hospital has facility-specific clinical practice guidelines (CPG) for patients | Yes | No | |||
80 | 27.5 | 72.5 | |||
Number of patients for whom physicians employ these CPG (among practices with CPGs, N = 23) | 23 | 0.0 | 8.7 | 4.4 | 87.0 |
Number of stage I and II breast cancer patients treated with MRM | 74 | 1.4 | 68.9 | 25.7 | 4.0 |
*Missing responses not included in percent calculations.